[ad_1]
Beijing, July 2, 2021 (Global News Agency)-Genetron Health Holdings Co., Ltd. (“Generic Health” or “Company”, NASDAQ:GTH) Is a leading precision oncology platform company in China, specializing in molecular profiling, early cancer screening products and companion diagnostic development, and announced the establishment of a new partnership with the World Economic Forum (WEF) under its health and healthcare platform.
As a platform partner, Genetron Health will contribute its research insights, technology and industry experience through future projects with the World Economic Forum. “Platforms shaping the future of health care”“As one of the industry participation platforms of the World Economic Forum, its goal is to ensure global equal access to the highest standards of health and medical care by helping stakeholders maintain population health and provide the best care. The platform also includes subject matter experts and researchers Including policy makers, academics and international organizations. Genetron Health and the World Economic Forum will work together to promote more influence and actions in the global healthcare industry.
Genya Dana, head of the World Economic Forum’s healthcare platform, said on the induction conference call…
The full story on Benzinga.com
[ad_2]
Source link
